Present recommendations in type 2 diabetes treatment.
Lebovitz
Harold E
HE
State University of New York Health Science in Brooklyn, Brooklyn, New York, USA. hlebovitz1@hotmail.com
D000465:Algorithms; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002170:Canada; D048909:Diabetes Complications / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D004704:Endocrinology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D007723:Korea; D024821:Metabolic Syndrome / Q000188:drug therapy / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014481:United States
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents